Biosynthesis of galactofuranose in kinetoplastids: Novel therapeutic targets for treating leishmaniasis and chagas' disease

33Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cell surface proteins of parasites play a role in pathogenesis by modulating mammalian cell recognition and cell adhesion during infection. β-Galactofuranose (Galf) is an important component of glycoproteins and glycolipids found on the cell surface of Leishmania spp. and Trypanosoma cruzi. β-Galf-containing glycans have been shown to be important in parasite-cell interaction and protection against oxidative stress. Here, we discuss the role of β-Galf in pathogenesis and recent studies on the Galf-biosynthetic enzymes: UDP-galactose 4′ epimerase (GalE), UDP-galactopyranose mutase (UGM), and UDP-galactofuranosyl transferase (GalfT). The central role in Galf formation, its unique chemical mechanism, and the absence of a homologous enzyme in humans identify UGM as the most attractive drug target in the β-Galf-biosynthetic pathway in protozoan parasites. © 2011 Michelle Oppenheimer et al.

Cite

CITATION STYLE

APA

Oppenheimer, M., Valenciano, A. L., & Sobrado, P. (2011). Biosynthesis of galactofuranose in kinetoplastids: Novel therapeutic targets for treating leishmaniasis and chagas’ disease. Enzyme Research. https://doi.org/10.4061/2011/415976

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free